Pharmacists Play Essential Role in Tolerability for Patients on Oral Anticancer Agents
June 15th 2022Tina Saleh, PharmD, PGY1 specialty pharmacy resident at the University of Illinois Hospital and Health Science System, discusses how oral anticancer agents differ from infusions and how pharmacists can improve tolerability for patients.
Expert Discusses Role of Pharmacist in Managing Patients with T2D
June 13th 2022Katherine Harte, PharmD, a PGY2 ambulatory care pharmacy resident at the Rhode Island Hospital in Providence, Rhode Island, discusses the impact of pharmacist management on SGLT2 inhibitors and GLP-1 receptor agonist utilization in patients with type 2 diabetes mellitus.
Expert Discusses New Specialty Drugs That are in the Pipeline
June 12th 2022Aimee Banks, PharmD, BCPS, MSCS, clinical pharmacist in the Multiple Sclerosis Clinic at Vanderbilt University Medical Center, discusses new hematology, oncology, and autoimmune therapies in the pipeline that pharmacists should be aware of.
COVID-19 Pandemic Has Surprisingly Little Impact on Oral Oncolytic Adherence
June 4th 2022Kelly McAuliff, PharmD, BCOP, CSP, spoke about research into the impacts of the COVID-19 pandemic on oral oncolytic adherence, particularly for patients with ovarian cancer, prostate cancer, or chronic myelogenous leukemia.
Co-Founder of House Rx Discusses The Company's Technology Platform and Pharmacy Service
June 2nd 2022Ogi Kavazovic, co-founder and CEO of House Rx, discusses the company's technology platform and pharmacy service and how it can better enable community oncology pharmacy practices to offer medically integrated dispensing.
Managing Allergic Rhinitis in Special Populations, A Holistic Approach
June 1st 2022A panel of experts discuss allergic rhinitis and important counseling points and tactics. They review the current standard of care and identify specific treatment considerations for children, women, elderly, and others.